Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5791)	10/22/1998 11:11:00 PM
From: Andrew H	Read Replies (2) \| Respond to of 9719

>> The death of AMLN is not a sure thing.<< I agree, although it looks probable. The market always overkills when something like this happens. And as you say downside is very very small. I wonder how many millions have been spent by AMLN and J and J altogether--must be more than 1/2 billion, anyway, probabloy closer to a billion. Sad story. I think there may be substantial upside for GZTC over the next 6 months, perhaps a double, although you are right that there will be no profits for quite a while. But they are making great progress in their collaborations--lots of companies going after them. We will have to see how the overall market does and biotechs in particular. But the bios are showing signs of life these days. Guess it must be the time of year. I'm doing well altho dreading the onset of winter. No more all wheel drive but we got all season Michelins which do the trick in well manicured Boulder. Looks like the VD thread has become a well respected and entrenched feature of SI. Congrats.